Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D2 Supplementation for CKD-SHPT
NCT05549154Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Dec 2022
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of vitamin d in secondary hyperparathyroidism (SHPT) and Vitamin D deficiency (VDD) (3 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Differences in changes in PTH levels from baseline to 6 months of intervention. Status: unknown.
02
Drugs
vitamin d
03
Conditions
secondary hyperparathyroidism (SHPT)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT05549154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05549154.